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at outpatient follow-up appointments 
and blood pressure control among patients 
with hypertension
Sajid Mahmood1, Zahraa Jalal2, Muhammad Abdul Hadi2 and Kifayat Ullah Shah1* 
Abstract 
Objective: The aim of this study was to assess the impact of regularity in treatment follow-up appointments on 
treatment outcomes among hypertensive patients attending different healthcare settings in Islamabad, Pakistan. 
Additionally, factors associated with regularity in treatment follow-up were also identified.
Methods: A cross-sectional study was undertaken in selected primary, secondary and tertiary healthcare settings 
between September, 2017 and December, 2018 in Islamabad, Pakistan. A structured data collection form was used to 
gather sociodemographic and clinical data of recruited patients. Binary logistic regression analyses were undertaken 
to determine association between regularity in treatment follow-up appointments and blood pressure control and to 
determine covariates significantly associated with regularity in treatment follow-up appointments.
Results: A total of 662 patients with hypertension participated in the study. More than half 346 (52%) of the patients 
were females. The mean age of participants was 54 ± 12 years. Only 274 (41%) patients regularly attended treatment 
follow-up appointments. Regression analysis found that regular treatment follow-up was an independent predic-
tor of controlled blood pressure (OR 1.561 [95% CI 1.102–2.211; P = 0.024]). Gender (OR 1.720 [95% CI 1.259–2.350; 
P = 0.001]), age (OR 1.462 [CI 95%:1.059–2.020; P = 0.021]), higher education (OR 1.7 [95% CI 1.041–2.778; P = 0.034]), 
entitlement to free medical care (OR 3.166 [95% CI 2.284–4.388; P = 0.0001]), treatment duration (OR 1.788 [95% CI 
1.288–2.483; P = 0.001]), number of medications (OR 1.585 [95% CI 1.259–1.996; P = 0.0001]), presence of co-morbidity 
(OR 3.214 [95% CI 2.248–4.593; P = 0.0001]) and medication adherence (OR 6.231 [95% CI 4.264–9.106; P = 0.0001]) 
were significantly associated with regularity in treatment follow-up appointments.
Conclusion: Attendance at follow-up visits was alarmingly low among patients with hypertension in Pakistan which 
may explain poor treatment outcomes in patients. Evidence-based targeted interventions should be developed and 
implemented, considering local needs, to improve attendance at treatment follow-up appointments.
Keywords: Cross sectional study, Blood pressure, Pakistan, Medication adherence, Primary care, Treatment follow-up
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Introduction
According to the World Health Organisation report, 
hypertension is the leading cause of morbidity and mor-
tality in the world and is responsible for nine million 
deaths every year [1]. Despite the availability of differ-
ent treatment options, the rate of blood pressure control 
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remains suboptimal [2, 3]. In the United States of Amer-
ica alone, the cost associated with uncontrolled hyperten-
sion accounts for $131 billion annually [4]. Patients with 
hypertension, including those with controlled blood pres-
sure, are twice as likely to develop cardiovascular compli-
cations as compared to the patients without hypertension 
[5]. The risk of stroke and ischemic cardiac events can be 
reduced to one third if the systolic blood pressure is con-
trolled below 140  mmHg [6]. Effective control of blood 
pressure can only be achieved through lifelong care and 
regular follow-up [7, 8]. Regular treatment follow-up is 
an important component of effective disease manage-
ment especially for long term conditions [9, 10]. For 
patients with hypertension, treatment follow-up provides 
an opportunity for healthcare practitioners to adjust 
patient’s treatment regimen, assess patient’s adherence 
to the therapy, monitor any adverse effects and improve 
patient’s understanding of disease management [11–13]. 
The research has demonstrated that regular attendance 
at treatment follow-up appointments is associated with 
better treatment outcomes in patients with hypertension 
[8, 9, 14–16]. Several interventions have been tested to 
improve follow-up care among patients with chronic dis-
eases. These interventions include increased awareness 
among patients regarding the benefits of follow-up care, 
providing free medications, free transport vouchers, tel-
ephone/sms reminders and appointment assistance. All 
these interventions have shown positive effect on regu-
larity in follow-up care among patients [12, 17–19].
Although there is slight variation in recommenda-
tions for scheduling of treatment follow-up appoint-
ments among various hypertension treatment guidelines, 
all guidelines strongly recommend regular follow-up 
appointments to monitor treatment outcomes. The Euro-
pean Society of Hypertension (ESH) guidelines for man-
agement of arterial hypertension recommends frequent, 
at least once a month visit to a specialized healthcare 
facility until the optimal target blood pressure (BP) is 
achieved. Once the target BP is achieved a visit interval of 
few months is considered reasonable [20]. The American 
Heart Association (AHA) 2017 guidelines for prevention, 
detection, evaluation and management of high blood 
pressure in adults also recommend scheduling follow-up 
evaluation at monthly interval until target BP is achieved 
and should be reassessed every three to six months [21].
According to a recently published meta-analysis, the 
prevalence of hypertension in Pakistan was 26.4% [22]. 
The national health survey of Pakistan reported that only 
50% of patients with hypertension in Pakistan were diag-
nosed and of those who were diagnosed, only 50% had 
ever received any treatment for hypertension [23]. Simi-
larly the control rate of blood pressure was only 12.5% 
[23]. Both pharmacological and non-pharmacological 
interventions are required for optimal management of 
hypertension [24]. Despite of its importance, no data is 
available on the regularity of follow-up appointments, 
predictors of regularity in follow-up appointments and 
association between regular follow-up visits and blood 
pressure control among patients with hypertension in 
Pakistan. The purpose of this study was to assess the reg-
ularity in hospital follow-up appointments, determining 
factors predicting regularity in hospital follow-up visits 
and to find out the impact of regular treatment follow-
up visits on blood pressure control among hypertensive 
patients in Pakistan.. This paper is part of larger study 




The ethics approvals of the study were obtained from 
Bioethics committees/administrations of Quaid-i-Azam 
University, Islamabad, Pakistan, Pakistan Institute of 
Medical Sciences Islamabad (tertiary care hospital), Gov-
ernment CDA Hospital, Sector G-6/2 Islamabad (second-
ary care hospital) and Government CDA Medical Centre, 
Sector I-10 Islamabad (primary healthcare setting) (Ref-
erence number. BFC-FBS-QAU-2018–108,Dated: 
23/10/2018, F.1–1/2015/ERB/SZABMU Dated: 
28/08/2017 and CDA/DHS-14(1) (63)/2018/1077 Dated: 
09/10/2018). Informed written consent was obtained 
from each participant before enrolment in the study. The 
anonymity and confidentiality of the survey was guaran-
teed to each enrolled participant.
Study settings
The study was conducted in three different healthcare 
settings in Islamabad, the federal capital of Pakistan. 
These healthcare settings included one tertiary care 
hospital, one secondary care hospital and one primary 
healthcare clinic to allow better generalization of study 
findings.
Sample size calculation
The sample size was calculated using an online sample 
size calculator, Raosoft®. The overall minimum sample 
size was calculated to be 385 based on 95% confidence 
interval, 5% margin of error and 50% response distribu-
tion. We aimed to recruit at least 100 patients from each 
study center. The respondents were sampled consecu-
tively from all study centers.
Study design and participants
A cross-sectional methodological approach was adopted. 
Three hundred and eight patients were recruited from 
tertiary care hospital, 203 patients from secondary care 
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hospital and 151 patients from primary health care 
Centre (Fig.1). The participants were recruited from 
September, 2017 to December, 2018. All adult patients 
aged 18 and above, diagnosed with essential hyperten-
sion, using at least one antihypertensive medication and 
able to communicate in Urdu (Pakistan’s National Lan-
guage) were invited to participate in the study. Patient’s 
hand-held record was used to ascertain their eligibility 
to participate in the study. Hypertensive patients with 
comorbidities were also included in the study. Pregnant 
women, patients with mental health illnesses affecting 
their cognitive abilities (e.g. dementia, Parkinson’s dis-
ease) and those who could not communicate in Urdu lan-
guage were excluded from our study. Participation in the 
study was voluntary. Participants meeting the inclusion 
and exclusion criteria were recruited using consecutive 
sampling strategy from each of the participating centres.
Data collection
A structured self-administered and self-reported ques-
tionnaire was used to assess the regularity in treatment 
follow-up appointments. However, for illiterate partici-
pants the questionnaires were administered by the inter-
viewer. The data collection was divided into three steps. 
In the first step, a standard questionnaire was used to col-
lect sociodemographic data of the patient. In the second 
step, patient’s medical record was reviewed and relevant 
clinical data were extracted including status of blood 
pressure control, number/nature of co-morbidities, 
medication history, risk factors and follow-up schedule 
advised to the patient. The follow-up schedule advised 
to the patient was used for the assessment of treatment 
follow-up regularity. In the third step, the participants 
were asked following questions relating to the regularity 
in treatment follow-up visits: When did you visit your 
doctor last time for treatment follow-up? Do you think 
that you visit your doctor regularly for treatment follow-
up? After how many days/weeks/months do you visit 
your doctor for treatment follow-up? In last ten sched-
uled/advised visits, how many times have you missed 
your follow-up visit?. Eight items Morisky medication 
adherence scale (MMAS-8) questionnaire was used to 
assess medication adherence [25–28]. The participants 
with MMAS-8 score ≤ 6 were considered as adherent to 
their prescribed antihypertensive therapy.
Outcome measures and covariates
The primary outcome measure was regularity in follow-
up visits. A participant was considered as irregular in 
treatment follow-up visits if he/she had missed more 
than three out of 10 scheduled/advised follow-up visits 
[29–31]. The patients with hypertension were defined in 
accordance with the National Institute for Health and 
Care Excellence (NICE) treatment guidelines, 2011 for 
the management of hypertension. A blood pressure read-
ing of 140/90 and 150/90 was considered controlled for 
patients aged less than 80 years and more than 80 years 
respectively. Similarly, for the patients with kidney fail-
ure, eye or cerebrovascular damage the blood pressure 
level under 130/80 mmHg was considered as controlled 
[32]. The covariates were age, marital status gender, 
education level, profession, entitlement status,smoking 
status, number of medications prescribed, duration 
Fig. 1 Participant recruitment flow diagram
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of therapy, presence of comorbidities and medication 
adherence.
Statistical analysis
Statistical Package for Social Sciences (SPSS) version 21.0 
was used to perform statistical analysis. A P-value of less 
than 0.05 was considered statistically significant. The 
binary logistic regression analysis using Forward Likeli-
hood Ratio method was used to identify predictors asso-
ciated with regularity in treatment follow-up and blood 
pressure control. Correlation and Hosmer–Lemeshow 
Goodness of Fit test was performed to select best predic-
tion model.
Results
A total of 662 patients with hypertension participated 
in the study. Of 662 patients, 315 (48%) were male and 
346 (52%) were female. The mean (± S.D) age of partici-
pants was 54 (± 12) years. The mean (± S.D) duration of 
hypertension was 6 (± 6) years. The mean (± S.D) systolic 
blood pressure of participants was 148 mmHg (± 18) and 
mean (± S.D) diastolic blood pressure was 92  mmHg 
(± 11). The mean number of antihypertensive drugs used 
was 1.69 ± 0.7. Two hundred and sixty (39%) participants 
were obese. Two hundred and eighty-nine (44%) partici-
pants were using single antihypertensive agent and, 253 
(38%) participants were entitled to free medical care. 
Two hundred and ninety (44%) participants had at least 
one co-morbidity. The prevalence of diabetes among par-
ticipants was 15% 8% of participants had coronary artery 
disease [CAD], 1% patients had congestive heart failure 
[CHF] and 21% of participants had hyperlipidemia. The 
participants’ demographic characteristics are presented 
in Table 1. Less than half of the patients (41%) were regu-
lar in attending follow-up visits. Similarly, in terms of 
healthcare setting, the number of patients who were reg-
ular in attending their follow-up appointments in tertiary 
care, secondary care and primary care setting were 118 
(38%), 123 (61%) and 33 (22%) respectively. (Table 2).
Out of 662 participants, 253 patients were entitled 
to free medical care. Of the patients who were entitled 
to free medical care, 150 (58%) participants regularly 
attended treatment follow-up appointments. Whereas 
the patients who were not entitled to free medical care, 
only 124 (31%) participants attended regular treatment 
follow-up appointments (P = 0.0001) (Table 2).
The results of binary regression analysis found that 
gender, age, higher education, entitlement status, treat-
ment duration, number of medications, presence of co-
morbidity, medication adherence and blood pressure 
control were significantly associated with regularity in 
treatment follow-up appointments. Similarly marital 
status, body mass index (BMI) and profession had no 
significant association with regularity in treatment fol-
low-up visits. (Table 3).
For factors associated with treatment follow-up regu-
larity, the results of binary regression analysis showed 
that males were 1.7 times more likely to regularly attend 
follow-up meetings compared to females (OR 1.720 
[95% CI 1.259–2.3]). The participants aged ≥ 60  years 
of age were 1.5 times more likely to be regular in treat-
ment follow-up visits than participants who were under 
60  years of age (OR 1.462 [95% CI 1.059–2.020]). The 
participants who were entitled to free medical care were 
approximately three times more likely to attend follow-
up appointments regularly compared with patients who 
were not entitled to free medical care (OR 3.166 [95% 
CI 2.284–4.388]). Patients with a co-morbidity were 3.2 
times more likely to be regular in treatment follow-up 
visits than the patients without any co-morbidity (OR 
3.214 [95% CI 2.248–4.593]). Patients with good medica-
tion adherence were approximately six times more likely 
to be regular in attending treatment follow-up appoint-
ments compared to patients with poor medication adher-
ence (OR 6.231 [95% CI 4.264–9.106]) (Table 3).
Similarly, for blood pressure control the results of 
binary regression analysis showed that treatment fol-
low-up regularity, age, number of anti-hypertensive 
medications and medication adherence had significant 
association with blood pressure control. On the other 
hand, gender, body mass index (BMI), level of education, 
employment status, marital status, entitlement status, 
treatment duration and presence of co-morbidity had no 
significant association with controlled blood pressure. 
The results of binary regression analysis further revealed 
that odds of controlled blood pressure in patients who 
were regular in their treatment follow-up visits were 
1.5 times higher than the patients who were irregular 
in their treatment follow-up visits (OR 1.561 [95% CI 
1.102–2.211]). Similarly, the odds of controlled blood 
pressure were 1.08 times higher in males as compared to 
females (OR 1.08 [95% CI 0.753–1.543]), being 60 years 
of age and above (OR 1.638 [95% CI 1.168–2.297]). 
being unmarried/divorced/widowed (OR 1.257 [95% 
CI 0.757–2.087]), being university graduate (OR 1.229 
[95% CI 0.730–2.068]), being normal weight (OR 1.05 
[95% CI 0.743–1.482), being an officer (OR 1.462 [95% 
CI 0.661–3.236]), being entitled to free medical care (OR 
1.210[95% CI 0.858–1.707]), more than 05 years of treat-
ment duration (OR 1.246[95% CI 0.875–1.776]), having 
co-morbidity (OR 1.072 [95% CI 0.733–1.568]), being 
adherent to prescribed pharmacotherapy (OR 2.720[95% 
CI 1.890–3.915]). On the contrary the odds of controlled 
blood pressure decrease with every unit increase in no. of 
prescribed anti-hypertensive medications (OR 0.689[95% 
CI 0.538–0.882]). (Table 4).
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Discussion
The aim of this study was to assess the regularity in 
attending treatment follow-up appointments, factors 
determining regularity in follow-up appointments and to 
evaluate the impact of regular treatment follow-up vis-
its on treatment outcomes among patients with hyper-
tension in Islamabad, Pakistan. Overall, attendance at 
treatment follow-up visits was poor. Furthermore, posi-
tive association between regular treatment follow-up 
and controlled blood pressure was observed among 
hypertension patients attending different healthcare set-
tings. However, patients entitled to free medical care 
were more likely to attend treatment follow-up visits 
compared to the patients who had to pay from their own 
pocket.
Pakistan healthcare system consists of three tiers i.e. 
primary, secondary and tertiary healthcareand is run 
by both public and private sectors. Tertiary care hospi-
tals are the teaching hospitals located in big cities of the 
country [23, 33]. Free healthcare coverage is available to 
Table 1 Demographic and clinical characteristics of recruited patients
Patient characteristics Total study population (N = 662)
N %
Gender Male 315 48
Female 346 52
Age Mean (SD) 54 ± 12.3 years
 ≥ 60 231 35
˂60 431 65
Marital status Married 574 87
Unmarried/divorced/widow 88 13
BMI Overweight 260 39
Normal weight 401 61
Education level Graduate and above 98 15
Secondary and higher secondary 228 34
Primary and below 149 23
Uneducated 187 28
Profession Officers/higher management 63 10
Clerical staff 52 08
Workers/laborers 122 18
Self employed 15 02
Retired/unemployed 115 17
House wives 295 45
Entitlement status Entitled 253 38
Non-entitled 409 62
Treatment duration Mean (SD) 06 ± 5.66 Years
 ≤ 5 years 442 67
 > 5 years 220 33




Co-morbidity Yes 177 27
No 485 73
Specific co-morbidity Patients with DM 96 15
Patients with CHD 53 08
Patients with CHF 05 0.8
Patients with Hyperlipidemia 136 21
Regularity in follow-up Regular Follow-up 274 41
Irregular Follow-up 388 59
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only 27% of the population which mostly include gov-
ernment employees and members of the armed forces 
of Pakistan. They either receive free medicines and other 
healthcare services from the hospital or through reim-
bursement in case a medicine or a healthcare service is 
not available in the hospital. The remaining 73% popu-
lation pay from their pockets for the healthcare services 
[34].
There is scarcity of research investigating the associa-
tion between regularity in treatment follow-up appoint-
ments and blood pressure control not only in Pakistan 
but also in the South Asian region. In line with previous 
findings, we found a positive association between regular 
treatment follow-up and controlled blood pressure [8, 9, 
15, 16, 35–37]. This positive association between regular-
ity in treatment follow-up and controlled blood pressure 
could be due to the fact that the regular treatment fol-
low-up visits provides an opportunity to healthcare pro-
viders to educate patients about their disease and drug 
therapy, optimize their therapy and to monitor treatment 
outcomes. There is a need to develop policies aiming 
at facilitating the patients in their treatment follow-up 
appointments to ensure better treatment outcomes.
Our results also suggest that entitlement to free medi-
cal care was significantly associated with regularity in 
treatment follow-up appointments. This finding is also 
consistent with previously reported studies [29, 38]. 
Unaffordability of healthcare services is the main issue 
in many lower-middle and low-income countries includ-
ing Pakistan [39–41].. Health authorities should ensure 
that access to basic and specialised healthcare services is 
affordable for all the citizens.
A number of factors associated with regularity of 
treatment follow-up were identified in this study. It was 
observed that male patients were more regular in attend-
ing treatment follow-up appointments compared to the 
female patients. Gender differences in attending follow-
up appointments have been reported for other disease 
conditions as well [42, 43]. However, studies conducted 
in the United Kingdom and Canada have reported that 
female patients were more likely to attend treatment 
follow-up visits compared to their male counterparts 
[14, 44]. The differences in the findings can be explained 
by the differences in cultural and social values. In Paki-
stan, females often need a male guardian to accompany 
them to the hospital and their attendance at. follow-up 
appointments depend on the availability of an accompa-
nying person and this may lead to the less regularity in 
treatment follow-up among females. Female only clinics 
can potentially help overcome this barrier.
Age was found to be significantly associated with reg-
ularity in treatment follow-up visits. Previously, mixed 
results have been reported in literature for the associa-
tion between age and regular attendance at follow-up 
appointments [14, 42–45]. Increased disease severity 
or the presence of other co-morbidities among old age 
patients may encourage elderly patients to regularly 
attend treatment follow-up appointments. However, 
some studies found negative correlation between age 
and regularity in treatment follow-up [46]. This negative 
correlation may be due to memory loss, non-availability 
of any caregiver or deteriorated health condition of the 
patient.
Our study found that patients with university level 
qualification were more likely to attend treatment follow-
up visits. The results of our study are in line with previ-
ously conducted studies which also found a significant 
correlation between level of education and regularity 
in treatment follow-up visits [29, 47, 48]. Better disease 
knowledge and awareness about potential complications 
among university graduates may explain higher likeli-
hood to attend treatment follow-up visits.
Table 2 Regularity in  treatment follow-up Appointments among  patients with  hypertension stratified by  healthcare 
setting, entitlement to free medical care and blood pressure control






 Tertiary care hospital 308 118 [38] 190 [62]
 Secondary care hospital 203 123 [61] 80 [39]
 Primary healthcare centre 151 33 [22] 118 (78)
 Overall 662 274 [41] 388 [59]
Entitlement to free medical care
 Treatment follow-up appointments regu-
larity in entitled patients
258 150 [58] 108 [42]
 Treatment follow-up appointments regu-
larity in non-entitled patients
404 124 [31] 280 (69)
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In line with the findings of a pervious study [46], we 
found significant positive correlation between the num-
ber of medications used and the regularity in treatment 
follow-up visits. A higher number of medications often 
means greater disease severity which could motivate 
patients to regularly attend their follow-up appointments. 
Table 3 Factors predicting regularity in treatment follow-up appointments
Significant values are highlighted in bold
*P < 0.05
The level of adherence was measured through 8-items Morisky Medication Adherence Scale (MMAS-8). Use of the MMAS is protected by US copyright laws. Permission 
for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH. Use of the ©MMAS is protected by US copyright and registered 
trademark laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, 294 Lindura Court, Las Vegas, NV 89,138–4632; dmorisky@
gmail.com.The scale’s questions are available in the originally published article (25)








 Female 225 (65) 122 [35] 1
 Male 163 [52] 152 (48) 1.720 1.259–2.350 0.001*
Age
 < 60 Years 266 (62) 164 (38) 1
 ≥ 60 Years 121 (52) 110 (48) 1.462 1.059–2.020 0.021*
Marital status
 Married 342 (60) 232 (40) 1
 Unmarried/divorced/Widowed 46 (52) 42 (48) 1.346 0.858–2.111 0.196
Education 0.166
 Uneducated 116 (62) 71 (38) 1
 Primary or below 86 (58) 63 (42) 1.197 0.771–1.857 0.423
 Secondary and higher secondary 137 (61) 89 (39) 1.061 0.713–1.580 0.769
 Graduation and above 49 (49) 51 (51) 1.700 1.041–2.778 0.034*
BMI
 Normal weight 237 (59) 164 (41) 1
 Obese 151 (58) 110 (42) 1.053 0.767–1.444 0.750
Profession 0.384
 Retired/unemployed/house wives 248 (60) 162 (40) 1
 Officers 32 (51) 31 (49) 1.483 0.871–2.525 0.147
 Clerical staff 26 (50) 26 (50) 1.531 0.858–2.730 0.149
Worker/laborer 67 (55) 55 (45) 1.257 0.836–1.890 0.272
Self employed 15 (100) 0 (0) - - -
Entitlement status
 Non-entitled 283 (69) 126 (31) 1
 Entitled 105 (42) 148 (58) 3.166 2.284–4.388 0.0001*
Treatment duration
 ≤ 5 years 281 (63) 163 (37) 1
 > 5 years 107 (49) 111 (51) 1.788 1.288–2.483 0.001*
No. of medications
 1 199 (69) 90 (31)
 2 147 (50) 146 (50)
 3 41 (52) 38 (48) 1.585 1.259–1.996 0.0001*
Co-morbidities
 No 321 (66) 164 (34) 1
 Yes 67 (38) 110 (62) 3.214 2.248–4.593 0.0001*
Medication adherence
 Non-Adherent 211 (83) 44 (17) 1
 Adherent 177 (44) 230 (56) 6.231 4.264–9.106 0.0001*
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Similarly, in line with previous studies [14, 42], we found 
significant correlation between the presence of co-
morbidity and regularity in treatment follow-up visits. 
Hypertension is often an asymptomatic disease so the 
patients do not feel need for regular treatment follow-
up visits but the patients with any co-morbidity may 
Table 4 Factors predicting blood pressure control among included patients
Significant values are highlighted in bold
*P < 0.05
Parameter Uncontrolled B.P 
n (%)




 Female 187 (53.9) 160 (46.1) 1
 Male 158 (50.2) 157 (49.8) 1.08 0.753–1.543 0.337
Age
  < 60 Years 243 (56.5) 187 (43.5) 1
 ≥ 60 Years 102 (44.0) 130 (56.0) 1.638 1.168–2.297 0.004*
Marital status
 Married 305 (53.1) 269 (46.9) 1
 Unmarried/divorced/widowed 40 (45.5) 48 (54.5) 1.257 0.757–2.087 0.376
Education
 Uneducated 106 (56.7) 81 (43.3) 1
 Primary or below 73 (49.0) 76 (51.0) 1.431 0.904–2.265 0.126
 Secondary and higher secondary 116 (51.3) 110 (48.7) 1.328 0.875–2.018 0.183
 Graduation and above 50 (50.0) 50 (50.0) 1.229 0.730–2.068 0.437
BMI
 Obese 140 (53.6) 121 (46.4) 1
 Normal weight 205 (51.1) 196 (48.9) 1.05 0.743–1.482 0.782
Profession
 Retired/unemployed/house wives 216 (52.7) 194 (47.3) 1
 Officers 30 (47.6) 33 (52.4) 1.462 0.661–3.236 0.348
 Clerical staff 25 (48.1) 27 (51.9) 1.320 0.640–2.721 0.453
 Worker/laborer 65 (53.3) 57 (46.7) 1.276 0.746–2.185 0.374
 Self employed 09 (60) 06 (40) 1.228 0.387–3.897 0.728
Entitlement status
 Non-entitled 228 (55.7) 181 (44.3) 1
 Entitled 117 (46.2) 136 (53.8) 1.210 0.858–1.707 0.277
Treatment duration
  ≤ 5 years 247 (55.6) 197 (44.4) 1
 > 5 years 98 (45.0) 120 (55.0) 1.246 0.875–1.776 0.223
No. of medications
 1 149 (51.6) 140 (48.4)
 2 147 (50.2) 146 (49.8) 1
 3 48 (60.8) 31 (39.2) 0.689 0.538–0.882 0.003*
Co-morbidities
 No 265 (54.6) 220 (45.4) 1
 Yes 80 (45.2) 97 (54.8) 1.072 0.733–1.568 0.720
Medication adherence
 Non-Adherent 173 (67.8) 82 (32.2) 1
 Adherent 172 (42.3) 235 (57.7) 2.720 1.890–3.915 0.001*
Treatment follow-up regularity
 Irregular treatment follow-up 232 (59.8) 156 (40.2) 1
 Regular treatment follow-up 113 (41.2) 161 (58.8) 1.561 1.102–2.211 0.012*
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perceive themselves sicker and seek medical help more 
frequently. Our study reported a very strong associa-
tion between the medication adherence and regularity 
in treatment follow-up visits. This result is in line with 
previously conducted studies [49–51]. Similarly the result 
of our study suggests the significant correlation between 
the controlled blood pressure and regularity in treat-
ment follow-up visits. Regularity in treatment follow-up 
visits increases the likelihood of controlled blood pres-
sure in patients with hypertension. In every subgroup the 
patients who were regular in treatment follow-up visits 
had better rate of blood pressure control as compared to 
the patients who were regular in their treatment follow-
up visits. These results are in line with the findings of 
previously conducted studies [8, 9, 14, 52]. This increased 
blood pressure control could be possibly because the 
regular follow-up visits provide healthcare practitioners 
an opportunity to adjust the treatment regimen, edu-
cate the patient and assess the patient’s adherence to 
prescribed pharmacotherapy, resulting in better treat-
ment outcomes. Lastly high medication adherence was 
significantly associated with high rate of blood pressure 
control. The results of our study are self-explanatory and 
in line with a number of previous research studies than 
showed better treatment outcomes in patients with high 
medication adherence [3, 35, 53, 54].
Implications for clinical practice
The findings of our study have quite significant practice 
and policy implications. There is a need to design and 
implement interventions to improve attendance at treat-
ment follow-up appointments. In this study, we have 
identified several factors associated with regularity in 
treatment follow-up visits like gender, age, level of edu-
cation, entitlement status, treatment duration, number 
of medications, presence of co-morbidity, medication 
adherence and controlled blood pressure. Hence any 
intervention targeting at any of these factors could be 
helpful in improving attendance during treatment follow-
up appointments. These interventions need to be patient 
specific and patient related factors such as age, gender, 
health beliefs, culture, traditions and disease knowledge 
should be kept in mind when designing any intervention 
to improve attendance at treatment follow-up visits. The 
intervention to increase regularity in treatment follow-up 
visits may include, providing entitlement to free medical 
care, educational interventions for educating the patients 
regarding the benefits of regular treatment follow-up, 
motivational interviewing, family support, providing bet-
ter services at healthcare settings, providing incentives to 
the patients on every visit for follow-up, sending remind-
ers to the patients through phone calls, sms, and emails 
etc. [55–62]. There is a need to educate the patients who 
are at early stage of their disease to carefully follow the 
instructions provided by the healthcare professionals to 
halt further progression of their disease and its compli-
cations. Given that attendance at follow-up visits is asso-
ciated with good BP control, healthcare professionals 
should emphasise the importance and purpose of attend-
ing follow-up visits during initial consultations. This will 
allow them to undertake required monitoring and opti-
mise medicines to ensure best possible treatment out-
comes for patients. In future studies, the distribution and 
causes of missed follow-up visits should also be explored 
in more detail.
Study limitations and future perspective
There are few limitations to our study findings. This study 
was conducted only in one city of Pakistan, hence gener-
alisation of findings to small towns and villages should be 
made with caution. We used self-reported questionnaires 
to access the regularity in treatment follow-up visits. 
Self-reported questionnaire has its own inherent disad-
vantages/limitation like patients ability to understand the 
questions in questionnaire and participant’s willingness 
to disclose his/her information. This may result in over 
or underestimation of the results. In addition, completing 
questionnaires involves recall of previous events which 
may lead to recall bias in old age patients or those who 
had been on treatment for many years.
Conclusion
Regularity in treatment follow-up appointments was 
poor in patients with hypertension attending different 
healthcare settings in Islamabad, Pakistan. There is an 
association between blood pressure control and regular-
ity in attending treatment follow-up appointments. On 
the basis of determining factors identified in our study, 
targeted interventions should be designed and imple-
mented for better therapeutic outcomes.
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